-+ 0.00%
-+ 0.00%
-+ 0.00%

Shiyao Innovation announced that the SYH2092 injection clinical trial application from the holding subsidiary Shiyao Group Jushi Biopharmaceutical Co., Ltd. was accepted on June 5, 2026. The “Drug Clinical Trial Approval Notice” approved and issued by the State Drug Administration was recently received, agreeing to carry out clinical trials of the drug domestically, and the company will conduct clinical trials in the near future.

Zhitongcaijing·08/27/2026 09:17:18
Listen to the news
Shiyao Innovation announced that the SYH2092 injection clinical trial application from the holding subsidiary Shiyao Group Jushi Biopharmaceutical Co., Ltd. was accepted on June 5, 2026. The “Drug Clinical Trial Approval Notice” approved and issued by the State Drug Administration was recently received, agreeing to carry out clinical trials of the drug domestically, and the company will conduct clinical trials in the near future.